A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Clinical trial NCT03669393 · COMPLETED

Trial details

NCT number: NCT03669393
Sponsor: ThromboGenics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Retinal Telangiectasis Idiopathic Juxtafoveal Retinal Telangiectasia

Start date: 2018-09-18
Primary completion: 2019-11-22
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.